Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.
Adolescent
Adult
Aged
Biopsy
Child
Child, Preschool
Contrast Media
Diagnosis, Differential
Female
Glioma
/ diagnostic imaging
Histones
/ genetics
Humans
Immunohistochemistry
Infant
Machine Learning
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Mutation
Retrospective Studies
Sensitivity and Specificity
Spinal Cord Neoplasms
/ diagnostic imaging
Diffuse midline glioma
Histone H3 K27M
Random forest
Spinal cord glioma
Journal
Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
19
09
2018
accepted:
03
01
2019
pubmed:
22
1
2019
medline:
9
4
2019
entrez:
22
1
2019
Statut:
ppublish
Résumé
Diffuse midline glioma with histone H3 K27M mutation is a new entity described in the 2016 update of the World Health Organization Classification of Tumors of the Central Nervous System. The purpose of this study was to evaluate the clinical and imaging characteristics to predict the presence of H3 K27M mutation in spinal cord glioma using a machine learning-based classification model. A total of 41 spinal cord glioma patients consisting of 24 H3 K27M mutants and 17 wild types were enrolled in this retrospective study. A total of 17 clinical and radiological features were evaluated. The random forest (RF) model was trained with the clinical and radiological features to predict the presence of H3 K27M mutation. The diagnostic ability of the RF model was evaluated using receiver operating characteristic (ROC) analysis. Area under the ROC curves (AUC) was calculated. MR imaging features of spinal cord diffuse midline gliomas were heterogeneous. Hemorrhage was the only variable that was able to differentiate H3 K27M mutated tumors from wild-type tumors in univariate analysis (p = 0.033). RF classifier yielded 0.632 classification AUC (95% CI, 0.456-0.808), 63.4% accuracy, 45.8% sensitivity, and 88.2% specificity. Our findings indicate that clinical and radiological features are associated with H3 K27M mutation status in spinal cord glioma.
Identifiants
pubmed: 30662997
doi: 10.1007/s00234-019-02154-8
pii: 10.1007/s00234-019-02154-8
doi:
Substances chimiques
Contrast Media
0
Histones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
313-322Références
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
Neurosurgery. 2011 Jan;68(1):188-97; discussion 197
pubmed: 21099707
Nat Genet. 2012 Jan 29;44(3):251-3
pubmed: 22286216
Acta Neuropathol. 2012 Sep;124(3):439-47
pubmed: 22661320
Cancer Cell. 2012 Oct 16;22(4):425-37
pubmed: 23079654
Science. 2013 May 17;340(6134):857-61
pubmed: 23539183
Genes Dev. 2013 May 1;27(9):985-90
pubmed: 23603901
Cancer Cell. 2013 Nov 11;24(5):660-72
pubmed: 24183680
Cancer Cell. 2013 Nov 11;24(5):567-74
pubmed: 24229707
Neuro Oncol. 2014 Jan;16(1):140-6
pubmed: 24285547
Acta Neuropathol. 2014 Oct;128(4):573-81
pubmed: 25047029
Science. 2014 Aug 29;345(6200):1065-70
pubmed: 25170156
Acta Neuropathol. 2015 Sep;130(3):435-7
pubmed: 26231952
Acta Neuropathol. 2015 Dec;130(6):815-27
pubmed: 26399631
Brain Pathol. 2016 Sep;26(5):569-80
pubmed: 26517431
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
AJNR Am J Neuroradiol. 2017 Apr;38(4):795-800
pubmed: 28183840
Neuro Oncol. 2017 Aug 1;19(8):1127-1134
pubmed: 28201752
Neuropathology. 2018 Apr;38(2):165-170
pubmed: 28880421